Clinical Trial Update: Etanercept Treating Patient With Acute ST Segment Elevated Myocardial Infarction [Phase 4]

View source ↗

Summary

This document provides an update on a Phase 4 clinical trial evaluating etanercept in a patient with acute ST-segment elevation myocardial infarction (STEMI).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-segment Elevation Myocardial Infarction

Drugs mentioned

• ENBREL (etanercept)

Snippet

Sponsor: Xijing Hospital | Conditions: Myocardial Infarction | Phase 4 | Status: UNKNOWN